PND9 COST UTILITY ANALYSIS OF LEVODOPA-CARBIDOPA VS LEVODOPA-CARBIDOPA-ENTACAPONE IN PARKINSON DISEASE IN MEXICO
Abstract
Authors
F Garcia-Contreras A Nevarez-Sida P Constantino-Casas E Rojas-Martínez M García-Constantino G Del Angel-García